Oncology Archives

Poster

Germline testing in Asian American and Pacific Islander women with breast cancer

Oncology

Date:

Monday, Jun 1, 2026 1:30pm – 4:30pm

Conference:

ASCO 2026

Authors:

Jennifer Tseng, John Michael O Ranola, Kristin Kohler, Magan Trottier

Collaborators:

City of Hope

Abstract Poster

Poster

Actionable germline findings in endometrial cancer from a large multigene panel tested cohort

Oncology

Session:

#572

Date:

Monday, Jun 1, 2026 1:30pm – 4:30pm

Conference:

ASCO 2026

Authors:

Adela Rodriguez-Hernandez, Brittany L. Bychkovsky, Carolyn Horton, Huma Rana, Jessica D. St. Laurent, Judy E. Garber, Linda M. Polfus, Magan Trottier, Miki Horiguchi

Collaborators:

Dana Farber Cancer Institute

Harvard Medical School

Massachusetts General Hospital

Abstract Poster

Poster

Germline Pathogenic/Likely Pathogenic (P/LP) Variants in Epithelial Neuroendocrine Neoplasms: The Case for Universal Germline Genetic Testing

Oncology

Session:

#165

Date:

Saturday, May 30, 2026 9:00am – 12:00pm

Conference:

ASCO 2026

Authors:

Andrew Bellizzi, Brittany Sears, Cassidy Carraway, Chandrikha Chandrasekharan, Daniel M. Halperin, Jennifer A. Chan, Matthew Gao, Olatunji B. Alese, Po HEar, Renuka Iyer, Seth Jason Concors, Simron Singh, Udhayvir Singh Grewal

Collaborators:

Dana Farber Cancer Institute

Emory University

Harvard Medical School

Roswell Park Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

University of Iowa

University of Toronto

Abstract

Poster

Germline Pathogenic Variants in Individuals with Renal Cell Carcinoma

Oncology

Session:

#IP71-05

Date:

Sunday, May 17, 2026 3:30pm – 5:30pm

Conference:

AUA 2026

Authors:

Carolyn Horton, Cassidy Carraway, Huma Rana, Magan Trottier, Michael Serzan, Miki Horiguchi

Collaborators:

Dana Farber Cancer Institute

Abstract Poster

Poster

Clinical impact of integrating BRCA2 MAVE data for variant reclassification: A real‑world evaluation

Oncology

Session:

#96

Date:

Tuesday, May 26, 2026 12:00am – 12:00am

Conference:

MSS 2026

Authors:

Ashley P.L. Marsh, Colin Young, PhD, Daniel Zimmerman, Jamie Weyandt, PhD, Kristin Kohler, Magan Trottier, Marcy E. Richardson, Sarah Dugger, Steven Harrison

Abstract Poster

Poster

Heterogeneity of pancreatic cancer risk across germline susceptibility genes and sex

Oncology

Session:

#9

Date:

Thursday, Mar 5, 2026 12:30pm – 2:30pm

Conference:

InSiGHT 2026

Authors:

Adam Chamberlin, Cassidy Carraway, Danielle Braun, Enako Matsumoto, Fay Kastrinos, Giovanni Parmigiani, Joy A. Xu, Laufey T. Amundadottir, Linda M. Polfus, Rachid Karam, PhD

Collaborators:

Columbia University Irving Medical Center

Dana Farber Cancer Institute

Harvard University

National Cancer Institute

Abstract Poster

Presentation

A multiplex assay of variant effect (MAVE) of MSH6 enables accurate, prospective Lynch Syndrome clinical variant interpretation

Oncology

Session:

#99

Speakers:

Anthony Scott, Felicia Hernandez, Ashley PL Marsh, Kristin Kohler, Xiaoyan Jia, Sebastian Vishnopolska, Sami Belhadj, Matthew Varga, Grace Clark, Sajini Jayakody, Bala Burugula, Rachid Karam, Jacob Kitzman

Conference:

InSiGHT 2026

Friday, Mar 6, 2026 1:00am – 6:30pm

Collaborators:

University of Michigan

Abstract

Poster

Characterization of TMEM127-related tumor predisposition in a hereditary cancer cohort

Oncology

Date:

Thursday, Mar 12, 2026 10:30am – 11:30am

Conference:

ACMG 2026

Authors:

Brittany Sears, Colin Young, PhD, Jamie Weyandt, PhD, Jeni Herrera-Mullar, June Mikkelson, Victoria Ellis

Poster Abstract

Poster

To fibroblast or not to fibroblast: Outcomes and clinical features of patients pursuing confirmatory germline testing following TP53‑positive results

Oncology

Date:

Thursday, Mar 12, 2026 10:30am – 11:30am

Conference:

ACMG 2026

Authors:

Athena Puski, Brooke Sample, Cassidy Carraway, Magan Trottier, Sarah Campian

Abstract Poster

Presentation

Cancer-specific risks associated with germline PALB2 pathogenic variants from a large clinical genetic testing cohort

Oncology

Speakers:

Yen Y. Tan, Chunling Hu, Huaizhi Huang, Nicholas Boddicker, Wenan Chen, Medha Kaul, Tara Rao, Alvaro N.A. Monteiro, Tina Pesaran, Rachid Karam, Susan M. Domchek, Siddhartha Yadav, Marcy E. Richardson, Fergus J. Couch

Conference:

SABCS 2025

Sunday, Oct 12, 2025 12:30pm – 1:30pm

Collaborators:

Institute of Medical Genetics, Medical University of Vienna

Mayo Clinic

Moffitt Cancer Center

University of Pennsylvania

Abstract

Oncology

Germline testing in Asian American and Pacific Islander women with breast cancer

Actionable germline findings in endometrial cancer from a large multigene panel tested cohort

Germline Pathogenic/Likely Pathogenic (P/LP) Variants in Epithelial Neuroendocrine Neoplasms: The Case for Universal Germline Genetic Testing

Germline Pathogenic Variants in Individuals with Renal Cell Carcinoma

Clinical impact of integrating BRCA2 MAVE data for variant reclassification: A real‑world evaluation

Heterogeneity of pancreatic cancer risk across germline susceptibility genes and sex

A multiplex assay of variant effect (MAVE) of MSH6 enables accurate, prospective Lynch Syndrome clinical variant interpretation

Characterization of TMEM127-related tumor predisposition in a hereditary cancer cohort

To fibroblast or not to fibroblast: Outcomes and clinical features of patients pursuing confirmatory germline testing following TP53‑positive results

Cancer-specific risks associated with germline PALB2 pathogenic variants from a large clinical genetic testing cohort

Patients

PROVIDERS

Solutions

Resources

Company

NOTICES

Oncology

Get in Touch

Helpful Links